T cells from patients with Guillain-Barré syndrome produce interferon-gamma in response to stimulation with the ganglioside GM1

J Clin Neurosci. 2010 Apr;17(4):537-8. doi: 10.1016/j.jocn.2009.07.096. Epub 2010 Jan 25.

Abstract

Guillain-Barré syndrome (GBS) is an acquired demyelinating neuropathy, characterized by infiltration of peripheral nerves with macrophages and T cells. There have been reports of antibodies to glycolipids in GBS. We have previously found T cell reactivity to glycolipids in patients with the demyelinating form of GBS. This study was performed to characterize the cytokines produced by these T cells. Peripheral blood lymphocytes from patients with GBS, chronic inflammatory demyelinating polyradiculoneuropathy, healthy control patients and other neuropathies were incubated with the ganglioside GM1 and transferred to enzyme-linked immunospot plates. The average number per well of spot-forming cells (SFC) in the absence of antigen was counted. The average spontaneous SFC number was subtracted from the average SFC number in the presence of GM1, to produce a corrected SFC. There was significantly increased production of interferon-gamma but not interleukin-5 in response to stimulation with the ganglioside GM1. This could indicate that SFC have a role in pathogenesis of disease.

MeSH terms

  • Cells, Cultured
  • Enzyme-Linked Immunosorbent Assay
  • G(M1) Ganglioside / immunology*
  • Guillain-Barre Syndrome / immunology*
  • Guillain-Barre Syndrome / metabolism
  • Humans
  • Interferon-gamma / biosynthesis*
  • Interferon-gamma / immunology
  • Interleukin-5 / biosynthesis
  • Interleukin-5 / immunology
  • T-Lymphocytes / immunology*
  • T-Lymphocytes / metabolism

Substances

  • Interleukin-5
  • G(M1) Ganglioside
  • Interferon-gamma